Collin Crowley Selected Research

Fructose

1/2021

Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Collin Crowley Research Topics

Disease

2	Alcoholic Fatty Liver 11/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 10/2020 - 11/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Insulin Resistance 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Obesity 01/2021
1	Hypertriglyceridemia 01/2021
1	Inflammation (Inflammations) 01/2020
1	Fibrosis (Cirrhosis) 01/2020

Drug/Important Bio-Agent (IBA)

2	Diacylglycerol O-AcyltransferaseIBA 11/2022 - 11/2019
1	ervogastatIBA 11/2022
1	FructoseIBA 01/2021
1	LipidsIBA 01/2021
1	EnzymesIBA 01/2021
1	Acetyl-CoA CarboxylaseIBA 10/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	Choline (Choline Chloride)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	AcyltransferasesIBA 11/2019
1	DiglyceridesIBA 11/2019